Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Swiss Med Wkly ; 152(15-16)2022 04 11.
Artigo em Inglês | MEDLINE | ID: mdl-35633633

RESUMO

BACKGROUND: Lung cancer is the leading cause of cancer-related deaths in Switzerland. Despite this, there is no lung cancer screening program in the country. In the United States, low-dose computed tomography (LDCT) lung cancer screening is partially established and endorsed by guidelines. Moreover, evidence is growing that screening reduces lung cancer-related mortality and this was recently shown in a large European randomized controlled trial. Implementation of a lung cancer screening program, however, is challenging and depends on many country-specific factors. The goal of this article is to outline a potential Swiss lung cancer screening program. FRAMEWORK: An exhaustive literature review on international screening models as well as interviews and site visits with international experts were initiated. Furthermore, workshops and interviews with national experts and stakeholders were conducted to share experiences and to establish the basis for a national Swiss lung cancer screening program. SCREENING APPROACH: General practitioners, pulmonologists and the media should be part of the recruitment process. Decentralisation of the screening might lead to a higher adherence rate. To reduce stigmatisation, the screening should be integrated in a "lung health check". Standardisation and a common quality level are mandatory. The PLCOm2012 risk calculation model with a threshold of 1.5% risk for developing cancer in the next six years should be used in addition to established inclusion criteria. Biennial screening is preferred. LUNG RADS and NELSON+ are applied as classification models for lung nodules. CONCLUSION: Based on data from recent studies, literature research, a health technology assessment, the information gained from this project and a pilot study the Swiss Interest Group for lung cancer screening (CH-LSIG) recommends the timely introduction of a systematic lung cancer screening program in Switzerland. The final decision is for the Swiss Cancer Screening Committee to make.


Assuntos
Detecção Precoce de Câncer , Neoplasias Pulmonares , Detecção Precoce de Câncer/métodos , Estudos de Viabilidade , Humanos , Neoplasias Pulmonares/diagnóstico por imagem , Projetos Piloto , Suíça , Tomografia Computadorizada por Raios X/métodos
2.
Nutr Rev ; 75(1): 49-60, 2017 01.
Artigo em Inglês | MEDLINE | ID: mdl-27974599

RESUMO

In light of evidence that high-dose iron supplements lead to a range of adverse events in low-income settings, the safety and efficacy of lower doses of iron provided through biological or industrial fortification of foodstuffs is reviewed. First, strategies for point-of-manufacture chemical fortification are compared with biofortification achieved through plant breeding. Recent insights into the mechanisms of human iron absorption and regulation, the mechanisms by which iron can promote malaria and bacterial infections, and the role of iron in modifying the gut microbiota are summarized. There is strong evidence that supplemental iron given in nonphysiological amounts can increase the risk of bacterial and protozoal infections (especially malaria), but the use of lower quantities of iron provided within a food matrix, ie, fortified food, should be safer in most cases and represents a more logical strategy for a sustained reduction of the risk of deficiency by providing the best balance of risk and benefits. Further research into iron compounds that would minimize the availability of unabsorbed iron to the gut microbiota is warranted.


Assuntos
Anemia Ferropriva/prevenção & controle , Dieta , Alimentos Fortificados , Ferro da Dieta/administração & dosagem , Ferro da Dieta/sangue , Anemia Ferropriva/dietoterapia , Anemia Ferropriva/tratamento farmacológico , Biofortificação , Suplementos Nutricionais , Relação Dose-Resposta a Droga , Microbioma Gastrointestinal , Hepcidinas/sangue , Humanos , Ferro da Dieta/farmacocinética , Malária/sangue , Malária/prevenção & controle , Estado Nutricional , Ensaios Clínicos Controlados Aleatórios como Assunto
3.
World Rev Nutr Diet ; 115: 211-23, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-27198518

RESUMO

Iron deficiency, one of the most widespread nutritional disorders, affects millions of people in emerging economies and, increasingly, in industrialized countries. Due to the high iron requirements during growth and development, infants and young children are among those most severely affected by iron deficiency. Iron deficiency that occurs during the critical phases of early life development has long-lasting health consequences that are reflected in increased risk of disease, reduced economic productivity and premature death, underscoring the importance of infants and young children as a key target group for addressing iron deficiency. This chapter focuses on the use of fortified foods as a cost-effective mechanism to address iron deficiency in this particularly vulnerable subpopulation. Nutritional policies that include food fortification need to be implemented within the context of effective public-private partnerships in order to address the fundamental mechanisms of accessibility, affordability and availability of nutritious food items for those in the lowest socio-economic strata.


Assuntos
Anemia Ferropriva/dietoterapia , Anemia Ferropriva/epidemiologia , Alimentos Fortificados , Ferro da Dieta/administração & dosagem , Anemia Ferropriva/sangue , Pré-Escolar , Análise Custo-Benefício , Países Desenvolvidos , Suplementos Nutricionais , Saúde Global , Humanos , Lactente , Ferro da Dieta/sangue
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA